259 related articles for article (PubMed ID: 27736318)
21. Inhibition of tolerance to spinal morphine antinociception by low doses of opioid receptor antagonists.
McNaull B; Trang T; Sutak M; Jhamandas K
Eur J Pharmacol; 2007 Apr; 560(2-3):132-41. PubMed ID: 17307158
[TBL] [Abstract][Full Text] [Related]
22. Morphine upregulates kappa-opioid receptors of human lymphocytes.
Suzuki S; Chuang TK; Chuang LF; Doi RH; Chuang RY
Adv Exp Med Biol; 2001; 493():81-7. PubMed ID: 11727785
[TBL] [Abstract][Full Text] [Related]
23. In vivo activation of a mutant mu-opioid receptor by naltrexone produces a potent analgesic effect but no tolerance: role of mu-receptor activation and delta-receptor blockade in morphine tolerance.
Roy S; Guo X; Kelschenbach J; Liu Y; Loh HH
J Neurosci; 2005 Mar; 25(12):3229-33. PubMed ID: 15788780
[TBL] [Abstract][Full Text] [Related]
24. Intrathecal morphine exacerbates paresis with increasing muscle tone of hindlimbs in rats with mild thoracic spinal cord injury but without damage of lumbar α-motoneurons.
Kawakami K; Tanaka S; Sugiyama Y; Mochizuki N; Kawamata M
PLoS One; 2022; 17(8):e0273095. PubMed ID: 35969631
[TBL] [Abstract][Full Text] [Related]
25. Kappa opioid antagonist effects of the novel kappa antagonist 5'-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys.
Negus SS; Mello NK; Linsenmayer DC; Jones RM; Portoghese PS
Psychopharmacology (Berl); 2002 Oct; 163(3-4):412-9. PubMed ID: 12373442
[TBL] [Abstract][Full Text] [Related]
26. Intrathecal minocycline does not block the adverse effects of repeated, intravenous morphine administration on recovery of function after SCI.
Rau J; Weise L; Moore R; Terminel M; Brakel K; Cunningham R; Bryan J; Stefanov A; Hook MA
Exp Neurol; 2023 Jan; 359():114255. PubMed ID: 36279935
[TBL] [Abstract][Full Text] [Related]
27. Intramuscular administration of morphine reduces mustard-oil-induced craniofacial-muscle pain behavior in lightly anesthetized rats.
Han SR; Lee MK; Lim KH; Yang GY; Jeon HJ; Ju JS; Yoon YW; Kim SK; Ahn DK
Eur J Pain; 2008 Apr; 12(3):361-70. PubMed ID: 17768078
[TBL] [Abstract][Full Text] [Related]
28. Pain-related depression of the mesolimbic dopamine system in rats: expression, blockade by analgesics, and role of endogenous κ-opioids.
Leitl MD; Onvani S; Bowers MS; Cheng K; Rice KC; Carlezon WA; Banks ML; Negus SS
Neuropsychopharmacology; 2014 Feb; 39(3):614-24. PubMed ID: 24008352
[TBL] [Abstract][Full Text] [Related]
29. Morphine analgesia after intrathecal administration of a narcotic agonist, chloroxymorphamine and antagonist, chlornaltrexamine.
Larson AA; Armstrong MJ
Eur J Pharmacol; 1980 Nov; 68(1):25-31. PubMed ID: 6161013
[No Abstract] [Full Text] [Related]
30. Lateralized kappa opioid receptor signaling from the amygdala central nucleus promotes stress-induced functional pain.
Nation KM; De Felice M; Hernandez PI; Dodick DW; Neugebauer V; Navratilova E; Porreca F
Pain; 2018 May; 159(5):919-928. PubMed ID: 29369967
[TBL] [Abstract][Full Text] [Related]
31. The impact of morphine after a spinal cord injury.
Hook MA; Liu GT; Washburn SN; Ferguson AR; Bopp AC; Huie JR; Grau JW
Behav Brain Res; 2007 May; 179(2):281-93. PubMed ID: 17383022
[TBL] [Abstract][Full Text] [Related]
32. Mu antagonist and kappa agonist properties of beta-funaltrexamine (beta-FNA) in vivo: long-lasting spinal analgesia in mice.
Qi JA; Heyman JS; Sheldon RJ; Koslo RJ; Porreca F
J Pharmacol Exp Ther; 1990 Mar; 252(3):1006-11. PubMed ID: 2156986
[TBL] [Abstract][Full Text] [Related]
33. Effect of norbinaltorphimine on ∆⁹-tetrahydrocannabinol (THC)-induced taste avoidance in adolescent and adult Sprague-Dawley rats.
Flax SM; Wakeford AG; Cheng K; Rice KC; Riley AL
Psychopharmacology (Berl); 2015 Sep; 232(17):3193-201. PubMed ID: 26025420
[TBL] [Abstract][Full Text] [Related]
34. Blocking mu opioid receptors in the spinal cord prevents the analgesic action by subsequent systemic opioids.
Chen SR; Pan HL
Brain Res; 2006 Apr; 1081(1):119-25. PubMed ID: 16499888
[TBL] [Abstract][Full Text] [Related]
35. Sex differences in locomotor effects of morphine in the rat.
Craft RM; Clark JL; Hart SP; Pinckney MK
Pharmacol Biochem Behav; 2006 Dec; 85(4):850-8. PubMed ID: 17217999
[TBL] [Abstract][Full Text] [Related]
36. Broad opioid antagonism amplifies disruption of locomotor function following therapy-like hindlimb stretching in spinal cord injured rats.
States GJR; Keller A; Shum-Siu A; Petruska JC; Magnuson DSK
Spinal Cord; 2022 Apr; 60(4):312-319. PubMed ID: 34561547
[TBL] [Abstract][Full Text] [Related]
37. The novel kappa-opioid receptor agonist TRK-820 suppresses the rewarding and locomotor-enhancing effects of morphine in mice.
Tsuji M; Takeda H; Matsumiya T; Nagase H; Narita M; Suzuki T
Life Sci; 2001 Mar; 68(15):1717-25. PubMed ID: 11270618
[TBL] [Abstract][Full Text] [Related]
38. Direct evidence for the involvement of the mesolimbic kappa-opioid system in the morphine-induced rewarding effect under an inflammatory pain-like state.
Narita M; Kishimoto Y; Ise Y; Yajima Y; Misawa K; Suzuki T
Neuropsychopharmacology; 2005 Jan; 30(1):111-8. PubMed ID: 15257306
[TBL] [Abstract][Full Text] [Related]
39. Effects of the selective dopamine D
Botz-Zapp CA; Foster SL; Pulley DM; Hempel B; Bi GH; Xi ZX; Newman AH; Weinshenker D; Manvich DF
Behav Brain Res; 2021 Oct; 415():113506. PubMed ID: 34352292
[TBL] [Abstract][Full Text] [Related]
40. Role of the kappa-opioid system in the attenuation of the morphine-induced place preference under chronic pain.
Suzuki T; Kishimoto Y; Misawa M; Nagase H; Takeda F
Life Sci; 1999; 64(1):PL1-7. PubMed ID: 10027746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
